You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石藥(01093.HK)高開7.6% 正就三項潛在合計約50億美元交易進行磋商
阿思達克 05-30 09:28
藍籌醫藥股石藥(01093.HK)今早(30日)高開7.61%,報8.2元,市前成交1,356.8萬股,涉資1.11億元。 石藥今早開市前宣布,目前正與若干獨立第三方就三項潛在交易進行磋商,涉及有關集團若干產品(包括表皮生長因子受體抗體藥物偶聯物(EGFR-ADC)及由集團技術平台開發的其他藥品)在開發、生產及商業化方面的授權及合作。 每項潛在交易項下,可能應付予集團的潛在首付款、潛在開發里程碑付款及潛在商業化里程碑付款,合計可能達到約50億美元。三項潛在交易中的其中一項目前已處於後期階段,預計將於6月完成。 目前,潛在交易的條款及條件尚未最終確定,集團亦未就潛在交易訂立任何具約束力的協議。因此,潛在交易未必一定會落實。 該股上日(29日)中午公布首季業績,營業額70.15億元人民幣(下同),按年跌21.9%。純利14.78億元,按年跌8.4%;每股盈利12.91分。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account